Patient Perceived Empathy of an AI Chatbot for Atrial Fibrillation Education
Patient Perceived Degree of Empathy Exhibited by Physician Guided, Prompt Engineered, Generative AI Chatbot Designed for Atrial Fibrillation Education
1 other identifier
interventional
40
1 country
1
Brief Summary
Atrial Fibrillation is a chronic disease with significant health consequences like increased risk of stroke, heart failure, heart attack and death. Educating patients about the disease is important for them to be able to understand the condition better, feel empowered and take an active part in their care plan. AI technology can potentially be used to impart such education. However, doing so with care and empathy is equally important. Therefore, it is necessary to ensure when AI technology is used to impart education about atrial fibrillation to patients, the humane aspects of the interaction are rigorously tested. This study examines a way to impart atrial fibrillation education through interaction with an AI chatbot, that uses text and links to educational videos. To participate in this study, people need to be age 18 or older and have a history of newly diagnosed atrial fibrillation. Approximately 40 individuals will be asked to take part in this study. The first step to the study will be reading through, understanding, and signing an informed consent. People who then agree to join the study will have a one-time interaction with the AI chatbot and structured educational material by using an iPad provided to them for the approximately 1 hour duration of the study. People in the study will obtain atrial fibrillation education by typing one by one on the iPad, up to 10 questions about the disease. Answers will include text and links to videos. Before and after atrial fibrillation education, people who join this study will be asked to fill out a survey. The study team will teach patients how to use the iPad and type in questions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 8, 2024
CompletedFirst Posted
Study publicly available on registry
November 12, 2024
CompletedStudy Start
First participant enrolled
November 25, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 2, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 2, 2025
CompletedJuly 8, 2025
November 1, 2024
5 months
November 8, 2024
July 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Empathy
Assess patient perceived degree of empathy exhibited by chatbot responses. The degree of empathy will be measured using a pre- and post- chatbot interaction 7 point Likert scale survey, with a higher score suggesting a higher level of perceived empathy. The title of the survey will be "Likert scale based survey for perceived empathy and trust," with the lowest score being 4 and the highest score being 28. Survey form available upon reasonable request.
From enrollment to end of interaction with chatbot, approximately an hour
Secondary Outcomes (2)
Knowledge
From enrollment to end of interaction with chatbot, approximately an hour
Trust
From enrollment to end of interaction with chatbot, approximately an hour
Study Arms (1)
Pilot interventional arm
EXPERIMENTALSingle arm, wherein all consenting participants undergoing interaction with chatbot for atrial fibrillation education.
Interventions
Atrial fibrillation education rendered through a generative AI chatbot, using an iPAD. The intervention itself is an approximately 1 hour long interaction with the chatbot or approximately 10 questions about atrial fibrillation, for 1 single interaction.
Eligibility Criteria
You may qualify if:
- Age greater than18 yrs
- Known diagnosis of atrial fibrillation
You may not qualify if:
- Inability to text/use an electronic device
- Inability to read English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UPMC Heart and Vascular Institute
Pittsburgh, Pennsylvania, 15213, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Samir Saba, MD
UPMC Heart and Vascular Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 8, 2024
First Posted
November 12, 2024
Study Start
November 25, 2024
Primary Completion
May 2, 2025
Study Completion
May 2, 2025
Last Updated
July 8, 2025
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share
Deidentified IPD may be shared at the discretion of investigators, upon reasonable request.